- Home
- IMCR vs KSS Comparison
IMCR vs KSS Comparison
Compare IMCR & KSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMCR
- KSS
- Stock Information
- Founded
- IMCR 2008
- KSS 1962
- Country
- IMCR United Kingdom
- KSS United States
- Employees
- IMCR N/A
- KSS N/A
- Industry
- IMCR Biotechnology: Biological Products (No Diagnostic Substances)
- KSS Department/Specialty Retail Stores
- Sector
- IMCR Health Care
- KSS Consumer Discretionary
- Exchange
- IMCR Nasdaq
- KSS Nasdaq
- Market Cap
- IMCR 1.7B
- KSS 1.9B
- IPO Year
- IMCR 2021
- KSS 1992
- Fundamental
- Price
- IMCR $34.26
- KSS $16.01
- Analyst Decision
- IMCR Buy
- KSS Sell
- Analyst Count
- IMCR 9
- KSS 14
- Target Price
- IMCR $57.00
- KSS $11.88
- AVG Volume (30 Days)
- IMCR 287.1K
- KSS 5.6M
- Earning Date
- IMCR 11-05-2025
- KSS 11-25-2025
- Dividend Yield
- IMCR N/A
- KSS 3.13%
- EPS Growth
- IMCR N/A
- KSS N/A
- EPS
- IMCR N/A
- KSS 1.86
- Revenue
- IMCR $356,145,000.00
- KSS $15,886,000,000.00
- Revenue This Year
- IMCR $29.71
- KSS N/A
- Revenue Next Year
- IMCR $11.27
- KSS N/A
- P/E Ratio
- IMCR N/A
- KSS $8.58
- Revenue Growth
- IMCR 26.78
- KSS N/A
- 52 Week Low
- IMCR $23.15
- KSS $6.04
- 52 Week High
- IMCR $39.33
- KSS $21.39
- Technical
- Relative Strength Index (RSI)
- IMCR 49.34
- KSS 51.40
- Support Level
- IMCR $33.92
- KSS $15.04
- Resistance Level
- IMCR $37.00
- KSS $17.06
- Average True Range (ATR)
- IMCR 1.45
- KSS 0.77
- MACD
- IMCR -0.06
- KSS -0.17
- Stochastic Oscillator
- IMCR 39.78
- KSS 32.17
About IMCR Immunocore Holdings plc
Immunocore Holdings PLC is a commercial-stage biotechnology company. Using its ImmTAX platform, the company is developing a deep pipeline in multiple therapeutic areas, including clinical stage programs in oncology and infectious disease, pre-clinical programs in autoimmune disease, and earlier pre-clinical programs across three therapeutic areas. The company's main product, KIMMTRAK, is used for the treatment of unresectable or metastatic uveal melanoma (mUM). The other drug candidates in its pipeline include Brenetafusp, IMC-P115C, IMC-T119C, IMC-R117C, IMC-S118AI, IMC-U120AI, and others, being developed as a potential treatment for various oncology, infectious, and autoimmune diseases.
About KSS Kohl's Corporation
Kohl's operates about 1,150 department stores in 49 states that sell moderately priced private-label and national brand clothing, shoes, accessories, cosmetics, and home furnishings. Most of these stores are in strip centers. Kohl's also has a large digital sales operation. Women's apparel is Kohl's largest category, having generated 25% of its 2024 sales. The retailer, headquartered in Menomonee Falls, Wisconsin, opened its first department store in 1962.